Video

Taking Obesity Treatment Into a Group Setting

Author(s):

Adam Hochron
Conference|Endocrine Society Annual Meeting

There are many ways to approach the problem of obesity. One new option is group therapy, bringing together many facets of treatment.

There are many ways to approach the problem of obesity. One new option is group therapy bringing together many facets of treatment.

Theodore Friedman, MD, PhD, from Charles Drew University discussed the inspiration behind this approach to treatment as well as the results of the process so far.

Related Videos
Pranav Garimella, MBBS, MPH | Credit: GlobalNewsWire
Caroline Piatek, MD: High HCRU, Patient Concerns Highlight Great Unmet Need in wAIHA
Steven W. Pipe, MD: Supporting Gene Therapy Implementation for Hemophilia
Corinna L. Schultz, MD: Improving Sickle Cell Trait Documentation in Infancy
Sibgha Zaheer, MD: Determining Washout Period With Fitusiran, Emicizumab Transition for Hemophilia
Pavan K. (Tem) Bendapudi, MD: Large-Scale Analyses Elucidate Genetic Risk of Thrombosis
Seema Rani, MD: Examining Sleep Health in Youth With SCD
Daniel Wang: A More Appropriate Ferritin Threshold is Cost-Effective for Iron Deficiency Screening
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Related Content
Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder | Image Credit: Rutgers University
February 2nd 2025

Tirzepatide Could Replace Daily Hormone Shots for Rare Genetic Fat Disorder

Connor Iapoce
Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D
January 31st 2025

Diabetes Dialogue: Understanding Semaglutide (Ozempic) in CKD and T2D

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
FDA News Month in Review: January 2025 | Image Credit: HCPLive
January 31st 2025

FDA News Month in Review: January 2025

Connor Iapoce
Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics| Image Credit: HCPLive
January 23rd 2025

Diabetes Dialogue: ADA’s 2025 Standards of Care in Diabetes Therapeutics

Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCE
Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results | Image Credit: Weill Cornell Medicine
January 27th 2025

Enobosarm Protects Lean Mass in Topline Phase 2b Trial Results

Connor Iapoce
Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use | Image Credit: University of Maryland
January 24th 2025

Thyroid Cancer Diagnoses Rise in First Year of GLP-1 RA Use

Connor Iapoce
© 2025 MJH Life Sciences

All rights reserved.